1SchwinnDA ,,MichelottiGA.α1Adrener gicreceptorsinthelowerurinarytractandvascularbed:potentialrolefortheα1dsub typeinfillingsymptomsandeffectsofage ingonvascularexpression[].British Journal of Urology.2000
2MalloyBJ,PriceDT,PriceRR ,etal.α1Adrenergicreceptorsubtypesinhumande trusor[].The Journal of Urology.1998
3Buzelin JM,Fonteyne E,Kontturi M,et al.Comparison of tamsulosin with alfuzosin in the treatment of patients with lower urinarty tract symptoms suggestive of bladder outlet obstruction ( symptomatic benign prostatic obstruction)[].British Journal of Urology.1997
4Mizobe T,Maze M,Lam V,et al.Arrangement of transmembrane domains in adrenergic receptors.Similarity to bacteriorhodopsin[].Journal of Biological Chemistry.1996
5Ford APDW,Daniels DV,Chang DJ,et al.Pharmacological pleiotropism of the human recombinant α1A-adrenoceptor: implications for α1- adrenoceptor classification[].British Journal of Pharmacology.1997
6Graham RM,Perez DM,Hwa J,et al.Alpha1-adrenergic receptor subtypes, molecular structure, function and signaling[].Circulation Research.1996
7Price D,Lefkowitz R,Caron M,et al.Localization of mRNA for three distinctα1Adrenergic subtypes in human tissues: implications for humanα-adrenergic physiology[].Molecular Pharmacology.1994
8Fitzpatrick JM.Facts and future lines of research in lower urinary tract symptoms in men and women: an overview of the role of α1- adrenoceptor antagonists[].British Journal of Urology.2000
9Andersson KE.Mode of action of α1- adrenoceptor antagonists in the treatment of lower urinary tract symptoms[].British Journal of Urology.2000
10Caine M.Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia[].Urologic Clinics of North America.1990
